New DRX-L Detector for Long-Length Digital Radiography Is Launched: Reports Carestream Health

Device Uses Multiple Sensors to Capture High-Resolution Images in Seconds; Single Exposure Improves Workflow While Reducing Dose

Carestream Health has introduced a new digital radiography detector in the United States and Canada, enabling hospitals and imaging centers that specialize in long-length imaging to increase productivity while decreasing both patient discomfort and dose.

Carestream Health notes with a single exposure, the CARESTREAM DRX-L Detector captures long-length images by providing a large field of view and high resolution for leg-length and spine exams. Since the image is acquired in one exposure, it decreases dose and overall exam time as compared to examinations that require multiple exposures. This approach minimizes discomfort by reducing the time that a patient needs to remain still.

“The new DRX-L Detector captures the entire long-length image dimensions—whether imaging the spine, performing a scoliosis exam or a hip-to-heel exam—with one single shot and one single exposure,” said Jill Hamman, Worldwide Marketing Manager at Carestream. “With traditional multi-shot digital radiography and multiple detectors, the technologist has to take separate shots to image the entire spine. That takes more set-up time as well as exam time.”

This can pose a challenge for patients with limited mobility or a pediatric patient with scoliosis who finds it challenging to be still. “When it’s very difficult for a patient to stand still or for any patient who is uncomfortable and in pain, even 15 seconds of capturing multiple diagnostic images can feel like an hour,” Ms. Hamman said.

A single-shot acquisition also minimizes the need for retakes and eliminates the need for the image to be manipulated and stitched due to patient movement. The DRX-L Detector uses Carestream’s ImageView Software with Eclipse Image Processing for high image quality and provides one unified image, without the need for modification. This detector also features the X-Factor, which means it can be shared with other compatible DRX equipment.

The DRX-L Detector supports a wide array of Carestream digital X-ray products, including:

“This detector will allow facilities to conduct critical long-length exams efficiently and seamlessly while delivering the highest level of care with imaging, diagnosing and treatment planning for patients,” Ms. Hamman added.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”
Exit mobile version